Fixed-dose Combination Approach for Asthma and COPD

Chronic airway inflammation and obstruction are common symptoms associated with chronic obstructive pulmonary disease (COPD) and asthma. Combination inhaled corticosteroids (ICS) and longacting β2 – agonist (LABA) products have a substantial impact on the management of these diseases.